Dementia and Alzheimer’s disease develop at elevated rates in older kidney transplant recipients and may threaten the health of their transplanted organ as well as their own survival, according to study published in the Journal of the American Society of Nephrology (JASN).
Older patients with kidney failure who receive a kidney transplant may develop dementia and Alzheimer’s disease related to their long-standing kidney disease and/or their need for neurotoxic immunosuppressant drugs to prevent rejection of their transplanted organ, the study authors said.
Mara McAdams-DeMarco, PhD, from Johns Hopkins Bloomberg School of Public Health and her colleagues studied 40,918 kidney transplant recipients aged ≥55 years and linked their information to Medicare claims data through the US Renal Data System.
Kidney transplant recipients had a 10-year dementia risk ranging from 5.1% for recipients aged 55 to 60 years to 17.0% for recipients aged ≥75 years; 10-year Alzheimer’s disease risk ranged from 1.0% to 6.7%, respectively. (For comparison with the general population, other research has reported a 1% to 1.5% incidence of dementia in adults aged 65 years and a 7.4% to 7.6% incidence in adults aged 75 years. For Alzheimer’s disease, a 0.6% to 0.9% incidence had been reported in adults aged 65 years and a 4.4% to 5.4% incidence in adults aged 75 years.) The strongest predictors for dementia and Alzheimer’s disease were older age and pre-transplant diabetes.
Recipients who developed dementia had a 43.1% chance of losing function of their transplanted kidney within 10 years, compared with a 28.8% chance in recipients who did not develop dementia. After adjustments, this corresponded to a 1.5-times increased risk for those with dementia. Similarly, recipients who developed dementia had an 89.9% chance of dying within 10 years, compared with a 55.7% chance in those without dementia, a 2.4-times increased risk after adjustments. Similar results concerning organ and patient survival were seen related to Alzheimer’s disease.
“There is the need for greater awareness of the risk for dementia and Alzheimer’s disease in older patients undergoing kidney transplantation. The risk of dementia and Alzheimer’s disease should be weighed against the burden of dialysis and not adversely impact the decision to transplant otherwise acceptable older transplant candidates,” said McAdams-DeMarco.
The article, entitled “Dementia and Alzheimer’s Disease among Older Kidney Transplant Recipients,” appears online at http://jasn.asnjournals.org